The paper concerns the ValueSec methodology and tool which support decisions related to the security measures selection in different application contexts. The ValueSec project, financed by the European Commission Seventh Framework Programme (FP7), considers security measures which properly affect risk, are cost effective, bring benefits and are free of different restrictions (political, social,...

This paper investigates the risk exposure arising from the supplier evaluation criteria of cost, quality, delivery, and flexibility. An integrated method of Fuzzy Decision Making Trial and Evaluation Laboratory (FDEMATEL) and Fuzzy Analytical Network Process (FANP), which is able to address interaction and feedback effects between the criteria and subjectivity in the decision rating, is used to...

Some people prefer to make risky decisions in their live, such as for avocation or even everyday decision making. Since Bauer first presented the conception of perceived risk in the decision making of consumer behavior, the role of perceived risk in product choice has attracted much attention and decisions such as choosing unknown objects have been known to be risky. Here in this study, we focu...

This chapter considers the natural hazard Risk Manager as an agent for choosing between interventions that affect the impact of future hazards. As such, it is possible to proceed broadly quantitatively, and to set aside the many less-quantifiable concerns that arise during a period of real-time hazard management. Thus the aim is to describe a framework in which it is possible to address questio...

EASE Estimation and Assessment of Substance Exposure is a knowledge based system for assessing workplace exposure to potentially hazardous new substances It was built for the Health and Safety Executive of the United Kingdom HSE EU regulations require a manufacturer of a new substance to notify the appropriate authority who will carry out a risk assessment of it To aid this process guidance is ...

Herpes simplex esophagitis (HSE) has rarely been reported in immunocompetent individuals. In a search of Medline until October 2012, we found only one case of HSE in a pregnant female. We present the first case of HSE in a healthy 36-year-old female at 27 weeks gestation who recovered without antiviral therapy.